FDA Approves Neurotoxic Flu Drug for Use on InfantsSubmitted by emalvini on Sat, 01/05/2013 - 19:29
FDA Approves Neurotoxic Flu Drug for Use on Infants
by Lisa Garber
January 5th, 2013 | Updated 01/05/2013 at 3:53 am
Tamiflu, the antiviral drug facing international criticism for its deadly side effects, has been approved by the US Food and Drug Administration for use on infants just two weeks old.
The FDA’s decision comes amidst international controversy over Tamiflu, known generically as oseltamivir. Since the drug’s approval in 1999, several suicide deaths and incidents of bizarre side effects have been recorded. In the UK, where use of Tamiflu was relatively low at the time of publication of a 2005 article, only 41 “yellow card” reports of adverse reactions were recorded, just one being agitation and two being “confusional states.”
In Japan, however, close to the cries of a then-imminent avian flu pandemic, 54 people with no previous discernible psychiatric or health complications were dead after taking Tamiflu in 2005.